Christiana S. Kappler, Ph.D.
Affiliations: | 2006 | Medical University of South Carolina, Charleston, SC, United States |
Area:
Cell Biology, Molecular BiologyGoogle:
"Christiana Kappler"Parents
Sign in to add mentorDonald R. Menick | grad student | 2006 | MUSC | |
(Pathways mediating sodium -calcium exchanger expression.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Giordano A, Liu Y, Armeson K, et al. (2019) Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. Plos One. 14: e0224420 |
Giordano A, Liu Y, Armeson K, et al. (2019) Abstract P5-03-03: Polo-like Kinase 1 (PLK1) inhibition synergizes with docetaxel in basal breast cancer cells Cancer Research. 79 |
Giordano A, Liu Y, Kappler C, et al. (2019) Polo-like kinase 1 inhibitor onvansertib synergizes with paclitaxel in breast cancer carrying p53 mutation Annals of Oncology. 30 |
Smith EL, Kappler CS, Ethier SP. (2017) Abstract 1339: Role of PTEN loss in basal-like 2 triple negative breast cancer Cancer Research. 77: 1339-1339 |
Irish JC, Mills JN, Turner-Ivey B, et al. (2016) Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer. Molecular Oncology |
Kappler CS, Smith EL, Ethier S. (2016) Abstract 4596: Regulation of epidermal growth factor receptor signaling in triple-negative breast cancer Cancer Research. 76: 4596-4596 |
Kappler CS, Guest ST, Irish JC, et al. (2015) Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer. Molecular Oncology. 9: 527-43 |
Kappler CS, Guest ST, Smith EL, et al. (2015) Abstract 1949: Oncogenic signaling in amphiregulin- and EGFR-expressing PTEN-null human breast cancer Cancer Research. 75: 1949-1949 |
Turner-Ivey B, Guest ST, Irish JC, et al. (2014) KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia (New York, N.Y.). 16: 644-55 |
Kappler C, Wilson R, Varughese B, et al. (2014) Abstract 3297: PTEN loss enhances amphiregulin-specific signaling and gene expression in triple-negative breast cancer Cancer Research. 74: 3297-3297 |